India to Algeria: Oxaliplatin Export Trade Route

The India to Algeria Oxaliplatin corridor is one of India's established pharmaceutical export routes, with 88 shipments documented worth a combined $2.9M USD. The route is dominated by ACCURE LABS PRIVATE LIMITED , which alone accounts for roughly 39% of all export value, reflecting the consolidated nature of India's oxaliplatin manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $33.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with oxaliplatin's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 10.2%, placing it at rank #18 among India's top oxaliplatin export destinations globally.

On the import side, key buyers of Indian oxaliplatin in Algeria include PHARMACIE CENTRALE DES HOPITAUX , PHARMACIE CENTRALE DES HOPITAUX, PHARMACIE CENTRALE DES HOPITAUX PC and 6 others. PHARMACIE CENTRALE DES HOPITAUX is the single largest importer with 38 shipments valued at $1.3M USD.

India's oxaliplatin exports to Algeria are driven primarily by a handful of large-scale manufacturers. ACCURE LABS PRIVATE LIMITED with 36 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Algeria benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ACCURE LABS PRIVATE LIMITED , SUN PHARMACEUTICAL INDUSTRIES LIMITED, ACCURE LABS PRIVATE LIMITED — together account for 91% of total trade value on this route. The average shipment value of $33.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as xylatin 100(oxaliplatin injection 100 mg)vls and xylatin 50 (oxaliplatin injection 50 mg) , suggesting that buyers in Algeria tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, PHARMACIE CENTRALE DES HOPITAUX is the largest importer with 38 shipments worth $1.3M USD — representing 43% of all oxaliplatin imports from India on this route. A total of 9 buyers are active on this corridor.